Tandy Hastings-Ison

Lanbotulinumtoxin-A: Safe for children with cerebral palsy but is it effective?

Tandy Hastings-Ison, Kerr Graham

Journal article  |  2022  |  DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Do randomised controlled trials evaluating functional outcomes following botulinum neurotoxin-A align with focal spasticity guidelines? A systematic review

Edwina Sutherland, Bridget Hill, Barby J Singer, Stephen Ashford, Brian Hoare, Tandy Hastings-Ison, Klemens Fheodoroff, Steffen Berwick, Fiona Dobson, Gavin Williams

Journal article  |  2022  |  DISABILITY AND REHABILITATION

PURPOSE: The impact of botulinum neurotoxin-A (BoNT-A) on functional outcomes when managing focal muscle spasticity remains unclea..

Clinical Trial Adherence to Focal Muscle Spasticity Guidelines: A Systematic Review

Edwina Sutherland, Bridget Hill, Barbara Singer, Brian Hoare, Tandy Hastings-Ison, Stephen Ashford, Klemens Fheodoroff, Steffen Berweck, Gavin Williams

Journal article  |  2021  |  Archives of Physical Medicine and Rehabilitation

Musculoskeletal Pathology in Cerebral Palsy: A Classification System and Reliability Study

H Kerr Graham, Pam Thomason, Kate Willoughby, Tandy Hastings-Ison, Renee Van Stralen, Benan Dala-Ali, Peter Wong, Erich Rutz

Journal article  |  2021  |  CHILDREN-BASEL

This article presents a classification of lower limb musculoskeletal pathology (MSP) for ambulant children with cerebral palsy (CP..

A synthesis and appraisal of clinical practice guidelines, consensus statements and Cochrane systematic reviews for the management of focal spasticity in adults and children

Gavin Williams, Barby J Singer, Stephen Ashford, Hoare Brian, Tandy Hastings-Ison, Klemens Fheodoroff, Steffen Berwick, Edwina Sutherland, Bridget Hill

Journal article  |  2020  |  DISABILITY AND REHABILITATION

OBJECTIVE: To identify and appraise the existing clinical practice guidelines, consensus statements and Cochrane systematic review..

Botulinum neurotoxin A, blinding, and bias

Tandy Hastings-Ison, Kerr Graham

Journal article  |  2020  |  DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY

Authors' Reply to K. Langdon and Colleagues' Comment on: "Botulinum Toxin in the Management of Children with Cerebral Palsy"

Iqbal Multani, Jamil Manji, Tandy Hastings-Ison, Abhay Khot, Kerr Graham

Journal article  |  2019  |  PEDIATRIC DRUGS

Botulinum Toxin in the Management of Children with Cerebral Palsy

Iqbal Multani, Jamil Manji, Tandy Hastings-Ison, Abhay Khot, Kerr Graham

Journal article  |  2019  |  PEDIATRIC DRUGS

During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used medical intervention in children with ce..

Onabotulinum toxin-A (Botox) for spastic equinus in cerebral palsy: a prospective kinematic study

T Hastings-Ison, M Sangeux, P Thomason, B Rawicki, M Fahey, HK Graham

Journal article  |  2018  |  JOURNAL OF CHILDRENS ORTHOPAEDICS

Purpose Botulinum toxin-A (or Botox) is widely used for the management of equinus gait in children with cerebral palsy but few rec..

Antibody responses to botulinum neurotoxin type A of toxin-treated spastic equinus children with cerebral palsy: A randomized clinical trial comparing two injection schedules

Minako Oshima, Philip Deitiker, Tandy Hastings-Ison, K Roger Aoki, H Kerr Graham, M Zouhair Atassi

Journal article  |  2017  |  JOURNAL OF NEUROIMMUNOLOGY

We have conducted a 26-month-long comparative study involving young patients (2-6years old) with a clinical diagnosis of spastic e..